Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer’s Disease Neuroimaging Initiative
By ACA |
We examined reasons for low mild cognitive impairment (MCI)-to-cognitively normal (CN) reversion rates in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Read More A rare missense variant of CASP7 is associated with familial late-onset Alzheimer’s disease
By ACA |
The genetic architecture of Alzheimer's disease (AD) is only partially understood.
Read More Dietary changes and cognition over 2 years within a multidomain intervention trial—The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
By ACA |
Association between healthy diet and better cognition is well established, but evidence is limited to evaluate the effect of dietary ...
Read More Subjective cognitive decline and rates of incident Alzheimer’s disease and non–Alzheimer’s disease dementia
By ACA |
In this multicenter study on subjective cognitive decline (SCD) in community-based and memory clinic settings, we assessed the (1) incidence ...
Read More Genetic screen in a large series of patients with primary progressive aphasia
By ACA |
Primary progressive aphasia (PPA) is a neurological syndrome, associated with both frontotemporal dementia and Alzheimer's disease, in which progressive language ...
Read More